SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Borland Scott

(Last) (First) (Middle)
2400 BAYSHORE PARKWAY SUITE 200

(Street)
MOUNTAIN VIEW CA 94043

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/21/2011
3. Issuer Name and Ticker or Trading Symbol
MAP Pharmaceuticals, Inc. [ MAPP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Neurology Franchise
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 981 D
Common Stock 321 I See Footnote(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (2) 03/05/2017 Common Stock 1,648 $3.363 D
Stock Option (Right to Buy) (2) 05/01/2017 Common Stock 1,589 $6.3897 D
Stock Option (Right to Buy) (3) 01/21/2018 Common Stock 10,000 $13.12 D
Stock Option (Right to Buy) (3) 02/10/2019 Common Stock 51,500 $10.37 D
Stock Option (Right to Buy) (3) 02/01/2020 Common Stock 35,000 $16.19 D
Resticted Stock Unit (4) 02/01/2020 Common Stock 10,000 (5) D
Stock Option (Right to Buy) (3) 01/25/2021 Common Stock 21,000 $16.15 D
Restricted Stock Unit (6) 01/25/2021 Common Stock 7,000 (5) D
Stock Option (Right to Buy) (3) 06/06/2021 Common Stock 13,750 $15.38 D
Restricted Stock Unit (7) 06/06/2021 Common Stock 4,500 (5) D
Stock Option (Right to Buy) (2) 03/06/2017 Common Stock 248 $3.363 I See Footnote(1)
Stock Option (Right to Buy) (2) 05/01/2017 Common Stock 4,237 $6.3897 I See Footnote(1)
Stock Option (Right to Buy) (3) 01/21/2018 Common Stock 2,500 $13.12 I See Footnote(1)
Stock Option (Right to Buy) (3) 02/10/2019 Common Stock 5,000 $10.37 I See Footnote(1)
Stock Option (Right to Buy) (3) 02/01/2020 Common Stock 4,375 $16.19 I See Footnote(1)
Stock Option (Right to Buy) (3) 01/25/2021 Common Stock 1,800 $16.15 I See Footnote(1)
Restricted Stock Unit (6) 01/25/2021 Common Stock 600 (5) I See Footnote(1)
Explanation of Responses:
1. Shares held by the spouse of the reporting person. The reporting person disclaims beneficial beneficiary ownership of the shares except to the extent of his pecuniary interest therein.
2. Fully exercisable.
3. The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested.
4. Vesting of the RSU award is performance-based.
5. Each RSU represents a contingent right to receive one share of MAP common stock.
6. 25% of the total number of RSUs vests and becomes payable on each anniversary of January 26, 2011, such that all RSUs subject to this award shall be fully vested on January 26, 2015.
7. 25% of the total number of RSUs vests and becomes payable on each anniversary of June 07, 2011, such that all RSUs subject to this award shall be fully vested on June 07, 2015.
/s/ Scott Borland 08/04/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.